Computed Tomography Assisted Biopsy: Clinical Trials

3 trials of Computed Tomography Assisted Biopsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 2 Phase 2, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Early Phase 11Recruiting 1

Follow Computed Tomography Assisted Biopsy: new trials by email Literature Review of Computed Tomography Assisted Biopsy trials Research Report on Computed Tomography Assisted Biopsy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Biospecimen Collection, Computed Tomography Assisted Biopsy, Dapagliflozin Propanediol - Lung Adenocarcinoma, Stage IA1 Lung Cancer American Joint Committee on Cancer (AJCC) v8
Early Phase 1RecruitingJonsson Comprehensive Cancer Center482025-12-022026-02-19
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Mezigdomide, Carfilzomib, Dexamethasone - Extramedullary Disease in Multiple Myeloma, Recurrent Multiple Myeloma
Phase 2RecruitingRoswell Park Cancer Institute282025-05-012026-08-18
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
Berzosertib, Computed Tomography Assisted Biopsy, Endoscopic Biopsy - Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8
Phase 2CompletedNational Cancer Institute (NCI)172020-11-162026-10-20

Conditions studied

Adenocarcinoma of Lung (1)  ·  Lung Neoplasms (1)  ·  Multiple Myeloma (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (3)

Top investigators

Claudio Scafoglio, MD/PhD (1)  ·  Jane Yanagawa, MD (1)  ·  Jens Hillengass, MD (1)  ·  Jordan D Berlin (1)

Results publications

PMID 41335461

NIH funding

UM1CA186689 (1)